Pfizer Stock: A Biotech Revolution? Brace for a Genomic Leap
Pfizer is advancing its position in next-generation biotechnology through new genomic technologies. The company is leveraging past successes in mRNA to enhance its genomic editing and gene therapy offerings. Integration of artificial intelligence with genomics is expected to significantly boost drug discovery
